Pavilion Publishing and Media Ltd
Blue Sky Offices Shoreham, 25 Cecil Pashley Way, Shoreham-by-Sea, West Sussex, BN43 5FF, UNITED KINGDOM
NICE’s decision not to recommend olaparib for prostate cancer patients “disappointing”
Olaparib, a drug used to treat advanced prostate cancer patients, will not be made available on the NHS, after The National Institute for Health and Care Excellence (NICE) said the treatment was not cost-effective.
---------------------------
This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.